ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint747,212 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical companyMassagnoLallemand Pharma AG
Lallemand Pharma AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

Lallemand Pharma AG develops and commercializes medicines and medical devices for respiratory conditions. Its products include sublingual tablets containing PMBL bacterial lysate and Healsea nasal sprays.

AI-generated
Offering

Products & services

Industry:Pharmaceutical company
✓ Offered4
Respiratory medicines and medical devices (PMBL, Healsea)
PMBL sublingual tablets for prevention of recurrent respiratory tract infections, plus Healsea nasal sprays with Symbiofilm® for acute respiratory symptoms and chronic rhinosinusitis.
Clinical research in respiratory diseases
Clinical research to extend the documentation and therapeutic applications of PMBL, and to demonstrate efficacy and safety of the nasal spray line in acute and chronic respiratory conditions.
Scientific respiratory health information
Knowledge pages on respiratory tract immunity, respiratory biofilm, and a health manual with explanations of mucosal surfaces, immune cells, and infection defence.
Partner services and marketing materials
Partner area with launch kits, publications database, press releases, and Healsea and Ismigen materials for distribution partners.
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Lallemand Pharma AG

Trust & reputation

ranQ Trust Score of Lallemand Pharma AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of November 2026

Without public customer reviews the score stays capped.

Lallemand Pharma AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Lallemand Pharma AG scores 89.3 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.100.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
Lallemand Pharma AG scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
Lallemand Pharma AG scores 97.1 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.97.14%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Lallemand Pharma AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of November 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Lallemand Pharma AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Lallemand Pharma AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Lallemand Pharma AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Lallemand Pharma AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Via Selva 2
6900 Massagno

At a glance

Legal form
Corporation
UID
CHE-113.998.852
Founded
2007 · 19 years
Last commercial register change
February 12, 2020
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    ZB
    Zambon Biotech SA
    Cadempino
    PS
    PUREXIS SA
    Gravesano
    GS
    GENIX1 SAGL
    Chiasso
    PS
    Promediol SA
    Montagnola
    IS
    Inceptua SA, Luxembourg, Succursale di Bioggio
    Bioggio
    DS
    DEVELOPHARMA SA
    Manno
    CS
    CoreQuest Sagl
    Lugano
    CP
    Chemo Project SA
    Lugano